Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

154.93

Aug 06 • 3:59 PM ET +0.02 (0.01%)

154.93

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC LABU

Scroll to Statements

Index	RUT
Market Cap	2.23B
Enterprise Value	1.99B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.55
P/C	8.53
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-73.62%
EPS next Y	-21.24%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	88.04%
Inst Trans	32.54%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.55%
SMA50	17.00%
SMA200	39.54%
Trades

Shs Outstand	14.31M
Shs Float	10.13M
Short Float	21.49%
Short Ratio	8.21
Short Interest	2.18M
52W High	161.38 -4.00%
52W Low	37.33 315.03%
Volatility	7.55% 7.93%
ATR (14)	10.48
RSI (14)	58.19
Beta	-0.23
Rel Volume	0.36
Avg Volume	265.19K
Volume	95,332

Perf Week	3.16%
Perf Month	6.71%
Perf Quarter	19.02%
Perf Half Y	88.92%
Perf YTD	48.02%
Perf Year	296.54%
Perf 3Y	724.10%
Perf 5Y	-49.04%
Perf 10Y	15.28%
Recom	1.00
Target Price	229.82
Prev Close	154.91
Price	154.93
Change	0.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)